SME_Combined_Sources_Sought_Presol_HHSNIHNCITSB0519025.pdf

COMBINED SOURCES SOUGHT AND PRE-SOLICITATION NOTICE

Title: Expert Consultant: Subject Matter Expert Consultancy Services to the National Cancer Institute’s (NCI), Center for Cancer Genomics (CCG) for the Genomic Data Commons (GDC).

Solicitation Number: RFQ# HHS-NIH-NCI-TSB-0519-025

Proposed Post Date: 06/04/2019

Proposed Response Date: 06/19/2019

Classification Code: R699

NAICS Code: 541690

Small Business Size Standard: $15 million

Contracting Office Address: Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 8490 Progress Drive Suite 400, Frederick, MD 21701

USA.

Description:

The National Cancer Institute (NCI), Center for Cancer Genomics (CCG), plans to procure on a sole source basis services for a Subject Matter expert in bioinformatics in the clinical research field, Martin Ferguson, Ph.D., H.D, 19 Canterbury Rd, Stow, MA., 01775.

The response close date of this notice is in accordance with FAR 5.203(a)(1). This acquisition will be processed under FAR part 12- Acquisition for Commercial Items and in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b)(2) and 41 U.S.C. 1901 and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 541690 “Other Scientific and Consulting Services,” and the business size standard is $15 million.

Only one award will be made as a result of this solicitation. This will be awarded as a combined Firm Fixed Price and Time and Materials type contract.

A severable base year plus three option years is anticipated for a period of performance of December 1, 2019 – August 20, 2023. Base Period of Performance: December 1, 2019- November 30, 2020; Option One: December 1, 2020- November 30, 2021; Option Two: December 1, 2021- November 30, 2022;

Option Three: December 1, 2022- August 20, 2023.

The NCI, CCG is a part of the National Institutes of Health. The NCI CCG’s goal is to integrate structural, functional, and computational tools with multiple cancer genomic datasets, which are then made broadly available via data commons to the research community. To this end, in June 2016, CCG launched the Genomics Data Commons (GDC), an integrated database to house multiple large-scale cancer genomics data sets with supporting analytical tools. The GDC is a growing, multi-petabyte collection of data generated by CCG Offices and other cancer genomic programs housed on a “big data” cloud-capable technology stack designed and built under contract to CCG. GDC currently includes data from

The Cancer Genome Atlas (TCGA) and the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) programs. Data from an additional 10 NCI-sponsored programs are slated to enter GDC over the next three years. A key requirement of data entering the GDC is that they must be harmonized into a single standard for maintenance and eventual comparability during analyses. As more data is added to the GDC, the system’s value to the research community multiplies.

The objectives of this procurement are to ensure the continued success of the GDC, a complex database and analytical software system that manages petabytes (and growing) of cancer genomic data. Much of the success of the GDC to date is dependent on understanding the nature of the data going into it, the lessons learned from prior systems holding cancer genome data and understanding modern architectures of system capable of managing such data.

The Contractor shall perform the following, unless otherwise noted:

Support for CCG’s critical programs is provided in three task areas, briefly described below and in the attached Statement of Work:

1. Task Area 1 - Center for Cancer Genomics (CCG): Provide expert guidance and support for with CCG’s oversight of the of the GDC to facilitate the continued development and utilization CCG’s Genomics Data Commons (GDC).

2. Task Area 2 – Office of Cancer Genomics (OCG): Provide support and expert technical guidance that facilitates policy and standards compliance and data normalization for Cancer Moonshot and other OCG programs.

3. Task Area 3 – TCGA Program Office:

a. Clinical Data Center (CDC) and Biospecimen Core Resource (BCR) Support: provide expert technical support for clinical data and biospecimen service ongoing operations.

b. Cancer Characterization Programs: provide expert technical guidance and services to support the closure of completed programs and ongoing activities of new programs.

Dr. Martin Ferguson is currently providing services including those above, to CCG under NCI contract HHSN261201700002A. Prior to this contract, Dr. Ferguson provided services to CCG under a subcontract with the Federally Funded Research and Development Center (FFRDC). He uniquely possesses the combination of program knowledge and relevant stakeholder experience to execute the activities we require to continue the development of the GDC in a timely fashion. Pursuant to FAR 6.302-1, Dr. Ferguson is the only known responsible source who will satisfy the agency program requirement.

REPORTING REQUIREMENTS AND DELIVERABLES:

Task Area Deliverable Submitted To Due Date All Monthly Status and

Accomplishments Report COR First business day of each month for the duration of the period of performance

2 Service Requirements Materials

TCGA Director and COR

As defined by TCGA Director and Contractor

3 Activity Reports on CDC and BCR Informatics Processes and Issues

TCGA Director, Individual Service Program Managers, and

COR

Weekly phone conferences; weekly written updates as requested by TCGA Director

All Accessibility Checklist COR Annually per deliverable format type

All Roster of Employee(s) Requiring Suitability Investigations

COR Within 30 calendar days of award and updated annually

All Non-Disclosure Agreement

COR Prior to beginning work on the contract.

All IT Security Awareness Training

COR Prior to beginning work on the contract and annually thereafter.

This notice is not a request for competitive quotation. However, if any interested party, especially small businesses, believes it can meet the above requirement, it may submit a capability statement which shall be considered by the agency. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow the NCI to determine if the party can perform the requirement.

Tailored capability statements should not exceed twenty (20) single sided pages including all attachments, resumes, charts, etc. (single spaced, 12-point font minimum) that clear details the firm’s ability to perform the aspects of the draft Statement of Work. Tailored capability statements should also include an indication of current certified small business status; this indication should be clearly marked on the first page of your capability statement (preferable placed under the eligible small business concern’s name and address) as well as the eligible small business concern’s name, point of contact, address and DUNS number.

Capability statements must be received in the contracting office by 12:00PM EST, on Wednesday June 19th, 2019. All responses must be in writing and sent electronically (via e-mail) to Kelly J. Fowler, Contract Specialist, at Kelly.Fowler@nih.gov in MS Word or Adobe Portable Document Format. The e-mail subject line must specify RFQ# HHS-NIH-NCI-TSB-0519-025. Facsimile responses will not be accepted. Capability statements received after this date and time will not be considered.

A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. The successful offeror must be registered and have a valid, current Entity Record, including current Representations and Certifications, in the System for Award Management (SAM) through SAM.gov.

Reference RFQ# HHS-NIH-NCI-TSB-0519-025 on all correspondence.

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work.

Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.

After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.

CONFIDENTIALITY: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

mailto:Kelly.Fowler@nih.gov